Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, novembre 13
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
ICU Medical Inc
ICUI
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$178.43
1.13
0.64%
À la clôture: Nov 13, 4:00 PM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
ICU Medical Financials
ICU Medical (ICUI) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
ICU Medical Affirms FY2026 GAAP EPS Guidance of $2.89-$3.29 vs $3.47 Est
ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $2.89-$3.29 to $2.89-$3.29 vs $3.47 analyst estimate..
Benzinga Newsdesk
PRO
ICU Medical Affirms FY2026 Adj EPS Guidance of $8.60-$9.00 vs $8.74 Est
ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $8.60-$9.00 to $8.60-$9.00 vs $8.74 analyst estimate..
Benzinga Newsdesk
PRO
ICU Medical Q3 Adj. EPS $2.44 Beats $2.14 Estimate, Sales $560.439M Beat $552.071M Estimate
ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.44 per share which beat the analyst consensus estimate of $2.14 by 14.02 percent. This is a 20.2 percent increase over earnings of $2.03 per share from the
Benzinga Newsdesk
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.
Avi Kapoor
PRO
ICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 Est
ICU Medical (NASDAQ:ICUI) raises FY2026 Adj EPS guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 analyst estimate..
Benzinga Newsdesk
PRO
ICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 Est
ICU Medical (NASDAQ:ICUI) raises FY2026 GAAP EPS guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 analyst estimate..
Benzinga Newsdesk
